Virtus ETF Advisers LLC Harpoon Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.69 - $7.83 $78,351 - $107,819	-13,770 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$7.88 - $14.0 $5,657 - $10,052	-718 Reduced 4.96%	13,770 $109,000
Q2 2021 Aug 10, 2021	SELL	$13.81 - $23.25 $93,410 - $157,263	-6,764 Reduced 31.83%	14,488 $201,000
Q1 2021 May 17, 2021	BUY	$17.65 - $24.16 $6,601 - $9,035	374 Added 1.79%	21,252 $445,000
Q4 2020 Feb 12, 2021	BUY	$12.83 - $17.84 $43,622 - $60,656	3,400 Added 19.45%	20,878 $347,000
Q3 2020 Nov 13, 2020	SELL	$11.01 - $18.52 $26,203 - $44,077	-2,380 Reduced 11.99%	17,478 $297,000
Q2 2020 Aug 05, 2020	BUY	$11.11 - $24.72 $220,622 - $490,889	19,858 New	19,858 $330,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.